Bioxyne LimitedASX: BXN

Funding from SOSE to Establish UK GMP Manufacturing Facility

· Issued by Bioxyne Limited

Filed with ASX · · 3 pages · English

Bioxyne Limited (ASX: BXN) (“Bioxyne” or “the Company”), through its subsidiary Breathe Life Sciences UK Ltd (BLSUK), is pleased to advise that it has received ~£850,000 in funding commitments from South of Scotland Enterprise, the economic development agency for the South of Scotland, to fit-out and establish its UK medicinal cannabis manufacturing and distribution facility. Key Highlights • The

Bioxyne Limited on 6ix

Earlier from Bioxyne

Later from Bioxyne

All Bioxyne news releases